MyBlueDots

WALTHAM, Mass.–(BUSINESS WIRE)–MDaudit, a premier provider of billing, coding compliance and revenue integrity software for health systems, hospitals, and provider groups, announced a strategic growth investment from Bregal Sagemount (“Sagemount”), a leading growth-focused private equity firm, and Primus Capital (“Primus”), the company’s existing investor. Terms of the transaction were not disclosed. MDaudit, headquartered in Waltham, MA, specializes in delivering high-quality, customer-centr

CAMBRIDGE, Mass.–(BUSINESS WIRE)–MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced the in-licensing of a next-generation selective PARP1 (poly ADP-ribose polymerase) inhibitor, now known as MOMA-989. The company also provided an update on the clinical progress of Polθ inhibitor MOMA-313 and outlined the clinical path for Werner inhibitor MOMA-341. “The addition of this selective PARP1 inhibitor

BOSTON–(BUSINESS WIRE)–PureTech to present at 43rd annual J.P. Morgan Healthcare Conference.

DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pharma professionals developing treatments for neurodegenerative disorders. The findings indicate that, despite recent successes in developing disease modifying treatments for Alzheimer’s, persistent challenges that remain in neurodegenerative clinical trials can be mitigated by underutilised trial me

TUTTLINGEN, Germany–(BUSINESS WIRE)–The family-owned MedTech company KARL STORZ is pleased to announce the acquisition of the medical business of T1V, a US-based visual collaboration software company. KARL STORZ has had a longstanding partnership with T1V to build its existing CollaboratOR portfolio. This acquisition marks a significant step for KARL STORZ in shaping integrated hardware and software solutions for digital surgery in global operating rooms, complementing its state-of-the-art en

BILLERICA, Mass.–(BUSINESS WIRE)—- $BRKR #BRKR–Bruker Corporation (Nasdaq: BRKR) today announced the launch of the LUMOS™ II ILIM, a quantum cascade laser (QCL) based infrared imaging microscope. The new LUMOS II ILIM redefines performance standards, enabling pharma and life science researchers to capture ultrafast IR images of expansive areas with enhanced spatial resolution. The LUMOS II ILIM features a patented coherence reduction method for infrared laser imaging essentially free from artifacts in both

BURLINGTON, Mass & NEW YORK–(BUSINESS WIRE)—- $BFLY #POCUS–Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”, “the Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2024 of approximately 35% year over year. Joseph DeVivo, Butterfly’s President, Chief Executive Officer and Chairman commented, “The Butterfly team closed out 2024

HOUSTON–(BUSINESS WIRE)–SynergenX Health and HerKare, two leading providers of hormone therapy and wellness services, are raising awareness about the life-changing benefits of testosterone replacement therapy (TRT) for women. Over the past decade, testosterone prescriptions have increased by almost 50% in the United States alone. Testosterone, often associated with men, is vital for women’s health, playing a key role in energy, mood, libido, and muscle maintenance. As women age, testosterone

RAHWAY, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Merck’s GARDASIL® Receives Expanded Approval for Males in China

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the second quarter of fiscal year 2025, which ended November 30, 2024. Fiscal Year 2025 Second Quarter Highlights   Quarter Ended November 30, 2024 Pro Forma* YoY Growth Pro Forma* Net Sa